Inhibition of extracellular vesicle pathway using neutral sphingomyelinase inhibitors as a neuroprotective treatment for brain injuryAsit Kumar,Santosh Kumar2349-2352
Neuroglobin and neuroprotection: the role of natural and synthetic compounds in neuroglobin pharmacological inductionLidia Ciccone,Susanna Nencetti,Simone Socci,Elisabetta Orlandini2353-2358
Potential effects of mesenchymal stem cell derived extracellular vesicles and exosomal miRNAs in neurological disordersMasako Nakano,Mineko Fujimiya2359-2366
Epidural electrical stimulation for spinal cord injuryElliot H.Choi,Sandra Gattas,Nolan J.Brown,John D.Hong,Joshua N.Limbo,Alvin Y.Chan,Michael Y.Oh2367-2375
Localization of the hydrogen sulfide and oxytocin systems at the depth of the sulci in a porcine model of acute subdural hematomaOscar McCook,Angelika Scheuerle,Nicole Denoix,Thomas Kapapa,Peter Radermacher,Tamara Merz2376-2382
Lithium beyond psychiatric indications: the reincarnation of a new old drugMatteo Haupt,Mathias Bähr,Thorsten R.Doeppner2383-2387
Abnormal metal homeostasis as a common drug target to combat neurodegenerative diseasesDagmar Pretsch2388-2389
Caspase-1: an important player and possible target for repair of the blood-brain barrier underlying neurodegenerationDaniel Rand,Itzik Cooper2390-2392
Light of the stars: calcium signals light up astrocytes in the presence of autoreactive CD4+ T cellsJelena Bogdanović Pristov,Ljiljana Nikolić2395-2396